0
ARTICLE |

Asthma FREE

Robert F. Lemanske, Jr, MD; William W. Busse, MD
JAMA. 1997;278(22):1855-1873. doi:10.1001/jama.1997.03550220061010
Text Size: A A A
Published online

For unknown reasons, the morbidity and mortality from asthma are increasing in many parts of the world, making it a global health concern. The heterogeneous nature of the clinical manifestations and therapeutic responses of asthma in both adult and pediatric patients indicate that it may be more of a syndrome rather than a specific disease entity. Numerous factors, including viral infections, allergen and irritant exposure, and exercise, among others, complicate both the short- and long-term management of asthma. Therapeutic intervention has focused on the appreciation that airway obstruction in asthma consists of bronchial smooth muscle spasm and variable degrees of airway inflammation characterized by edema, mucous secretion, and the influx of a variety of inflammatory cells. Choosing appropriate medications depends on the disease severity (intermittent, mild persistent, moderate persistent, severe persistent), patterns of disease activity (exacerbations related to viruses, allergens, exercise, etc), and the age at onset (infancy, childhood, adulthood).

REFERENCES

Sandford A, Weir T, Pare P.  The genetics of asthma . Am J Respir Crit Care Med . 1996;;153:1749-1765.
Cookson WOCM, Sharp PA, Faux JA, Hopkin JM.  Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q . Lancet . 1989;;1:1292-1295.
Moffatt MF, Sharp PA, Faux JA, Young RP, Cookson WOCM, Hopkin JM.  Factors confounding genetic linkage between atopy and chromosone 1 lq . Clin Exp Allergy . 1992;;22:1046-1051.
Marsh DG, Neely JD, Breazeale DR, et al.  Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations . Science . 1994;;264:1152-1156.
Postma DS, Bleecker ER, Amelung PJ, et al.  Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy . N Engl J Med . 1995;;333:894-900.
Moffatt MF, Hill MR, Cornelis F, et al.  Genetic linkage of T-cell receptor alpha/delta complex to specific IgE responses . Lancet . 1994;;343:1597-1600.
Lemanske RF Jr, Kaliner MA.  The assessment of autonomic nervous system function . In: Spector SL, ed. Provocative Challenge Procedures: Background and Methodology . Mount Kisco, NY: Futura Publishing Co Inc; 1989;:131-166.
Reihsaus EM, Innis M, MacIntyre N, Liggett SB.  Mutations in the gene encoding for the β2-adrenergic receptor in normal and asthmatic subjects . Am J Respir Cell Mol Biol . 1993;;8:334-339.
Green SA, Turki J, Innis M, Liggett SB.  Aminoterminal polymorphisms of the human β2-adrenergic receptor impart distinct agonist-promoted regulatory properties . Biochemistry . 1994;;33:9414-9419.
Turki J, Pak J, Green A, Martin RJ, Liggett SB.  Genetic polymorphisms of the β2-adrenergic receptor in nocturnal and nonnocturnal asthma . J Clin Invest . 1995;;95:1635-1641.
Hall IP, Wheatley A, Wilding P, Liggett SB.  Association of Glu 27 β2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects . Lancet . 1995;;345:1213-1214.
Bai TR, Mak JCW, Barnes PJ.  A comparison of beta-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle . Am J Respir Cell Mol Biol . 1992;;6:647-651.
Bai TR.  Abnormalities in airway smooth muscle in fatal asthma . Am Rev Respir Dis . 1990;;141:552-557.
Metzger WJ, Zavala D, Richerson HB, et al.  Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs: description of the model and local airway inflammation . Am Rev Respir Dis . 1987;;135:433-440.
Frick RB, Metzger WJ, Richerson HB, et al.  Increased bronchovascular permeability afterallergen exposure in sensitive asthmatics . J Appl Physiol . 1987;;63:1147-1155.
Wiggs BR, Bosken C, Pare PD, James A, Hogg JC.  A model of airway narrowing in asthma and in chronic obstructive pulmonary disease . Am Rev Respir Dis . 1992;;145:1251-1258.
Lundgren JD, Shelhamer JH.  Pathogenesis of airway mucus hypersecretion . J Allergy Clin Immunol . 1990;;85:399-417.
McFadden ER Jr, Gilbert IA.  Asthma . N Engl J Med . 1992;;327:1928-1937.
Salvato G.  Some histologic changes in chronic bronchitis and asthma . Thorax . 1968;;23:168-172.
Cutz E, Levison H, Cooper DM.  Ultrastructure of airways in children with asthma . Histopathology . 1978;;2:407-421.
Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI.  Cytokines in symptomatic asthma airways . J Allergy Clin Immunol . 1992;;89:958-967.
Vittori E, Marini M, Fasoli A, de Franchis R, Mattoli S.  Increased expression of endothelin in bronchial epithelial cells of asthmatic patients and effect of corticosteroids . Am Rev Respir Dis . 1992;;146:1320-1325.
Leff AR, Hamann KJ, Wegner CD.  Inflammation and cell-cell interactions in airway hyperresponsiveness . Am J Physiol . 1991;;260:L189-L206.
Colasurdo GN, Larsen GL.  Airway hyperresponsiveness . In: Busse WW, Holgate ST, eds. Asthma and Rhinitis . Boston, Mass: Blackwell Scientific Publications;1995;:1044-1056.
Hargreave FE, Dolovich J, O'Byrne PM, Ramsdale EH, Daniel EE.  The origin of airway hyperresponsiveness . J Allergy Clin Immunol . 1986;;78:825-832.
Smith L, McFadden ER Jr.  Bronchial hyperreactivity revisited . Ann Allergy Asthma Immunol . 1995;;74:454-469.
Hoag JE, McFadden ER Jr.  Long-term effect of cromolyn sodium on nonspecific bronchial hyperresponsiveness: a review . Ann Allergy . 1991;;66:53-63.
Lenfant C, Khaltaev N.  Global Initiative for Asthma . In: Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report . 1993;;1:1-176.
Evans R, Mullally DI, Wilson RW, et al.  National trends in the morbidity and mortality of asthma in the US . Chest . 1987;;91( (suppl) ):65S-74S.
Halfon N, Newacheck PW.  Childhood asthma and poverty: differential impacts and utilization of health services . Pediatrics . 1993;;91:56-61.
Call RS, Smith TF, Morris E, Chapman MD, Platts-Mills TAE.  Risk factors for asthma in inner city children . J Pediatr . 1992;;121:862-866.
Banner AS.  The increase in asthma prevalence . Chest . 1995;;108:301-302.
Jenkins MA, Hopper JL, Bowes G, Carlin JB, Flander LB, Giles GG.  Factors in childhood as predictors of asthma in adult life . BMJ . 1994;;309:90-93.
Oliveti JF, Kercsmar CM, Redline S.  Pre- and perinatal risk factors for asthma in inner city African-American children . Am J Epidemiol . 1996;;143:570-577.
Lemanske RF Jr, Kaliner MA.  Late phase allergic reactions . In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice . St Louis, Mo: Mosby-Year Book Inc; 1993;:320-361.
Niemeijer NR, de Monchy JGR.  Age-dependency of sensitization to aero-allergens in asthmatics . Allergy . 1992;;47:431-435.
Duff AL, Platts-Mills TAE.  Allergens and asthma . Pediatr Clin North Am . 1992;;39:1277-1291.
Platts-Mills TAE, Tovey ER, Mitchell EB, Moszoro H, Nock P, Wilkins SR.  Reduction of bronchial reactivity during prolonged allergen avoidance . Lancet . 1982;;1:675-678.
Reid MJ, Moss RB, Hsu YP, Kwasnicki JM, Commerford TM, Nelson BL.  Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy . J Allergy Clin Immunol . 1986;;78:590-600.
O'Hollaren MT, Yunginger JW, Offard KP, et al.  Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma . N Engl J Med . 1991;;324:359-363.
James JM, Bernhisel-Broadbent J, Sampson HA.  Respiratory reactions provoked by double-blind food challenges in children . Am J Respir Crit Care Med . 1994;;149:59-64.
Morgan WJ, Martinez FD.  Risk factors for developing wheezing and asthma in childhood . In: Stempel DA, Szelfer SJ, eds. Pediatric Clinics of North America . Philadelphia, Pa: WB Saunders Co; 1992;:1185-1203.
Halonen M, Stern D, Taussig LM, Wright A, Ray CG, Martinez FD.  The predictive relationship between serum IgE levels at birth and subsequent incidences oflower respiratory illnesses and eczema in infants . Am Rev Respir Dis . 1992;;146:866-870.
Martinez FD, Wright AL, Taussig LM, et al.  Asthma and wheezing in the first six years of life . N Engl J Med . 1995;;332:133-138.
Bleecker ER, Amelung PJ, Levitt RC, Postma DS, Meyers DA.  Evidence for linkage of total serum IgE and bronchial hyperresponsiveness to chromosome 5q: a major regulatory locus important in asthma . Clin Exp Allergy . 1995;;25:84-88.
Sunyer J, Anto JM, Castellsague J, Soriano JB, Roca J, Spanish Group of the European Study of Asthma.  Total serum IgE is associated with asthma independently of specific IgE levels . Eur Respir J . 1996;;9:1880-1884.
Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG.  Association of asthma with serum IgE levels and skin-test reactivity to allergens . N Engl J Med . 1989;;320:271-277.
Robinson DS, Hamid Q, Ying S, et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma . N Engl J Med . 1992;;326:298-304.
Anderson GP, Coyle AJ.  TH2 and 'TH2-like' cells in allergy and asthma: pharmacologic perspectives . Trends Pharmacol Sci . 1994;;15:324-332.
Cockcroft DW, Murdock KY.  Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, and increased bronchial responsiveness to histamine . J Allergy Clin Immunol . 1987;;79:734-740.
Brogden RN, Sorkin EM.  Nedocromil sodium: an updated review of its pharmacologic properties and therapeutic efficacy in asthma . Drugs . 1993;;45:693-715.
de Jong JW, Teengs JP, Postma DS, et al.  Nedocromil sodium versus albuterol in the management of allergic asthma . Am J Respir Crit Care Med . 1994;;149:91-97.
Pizzichini MMM, Kidney JC, Wong BJO, et al.  Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses . Eur Respir J . 1996;;9:449-455.
Twentyman OP, Finnerty JP, Holgate ST.  The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma . Am Rev Respir Dis . 1991;;144:782-787.
Lai CKW, Twentyman OP, Holgate ST.  The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in non-specific bronchial responsiveness . Am Rev Respir Dis . 1989;;140:917-923.
Page C, Costello J.  Why beta-agonists should not be used regularly . Respir Med . 1992;;86:477-479.
Martinez FD, Morgan WJ, Wright AL, Holberg C, Taussig LM.  Initial airway function is a risk factor for recurrent wheezing respiratory illnesses during the first three years of life . Am Rev Respir Dis . 1991;;143:312-316.
Martinez F, Cline M, Burrows B.  Increased incidence of asthma in children of smoking mothers . Pediatrics . 1992;;89:21-26.
Duff AL, Pomeranz ES, Gelber LE, et al.  Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens . Pediatrics . 1993;;92:535-540.
Cypcar D, Stark J, Lemanske RF Jr.  The impact of respiratory infections on asthma . Pediatr Clin North Am . 1992;;39:1259-1276.
Johnston SL, Pattemore PK, Sanderson G, et al.  Community study of role of viral infections in exacerbations of asthma in 9-11 year old children . BMJ . 1995;;310:1225-1228.
Nicholson KG, Kent J, Hammersley V, Cancio E.  Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study . BMJ . 1996;;313:1119-1123.
Lemanske RF Jr, Dick EC, Swenson CA, Vrtis RF, Busse WW.  Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions . J Clin Invest . 1989;;83:1-10.
Calhoun WJ, Dick EC, Schwartz LB, Busse WW.  A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects . J Clin Invest . 1994;;94:2200-2208.
Einarsson O, Geba GP, Zhu Z, Landry M, Elias JA.  Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness . J Clin Invest . 1996;;4:915-924.
Connett G, Lenney W.  Prevention of viral induced asthma attacks using inhaled budesonide . Arch Dis Child . 1993;;68:85-87.
Brunette MG, Lands L, Thibodeau L.  Childhood asthma: prevention of attacks with short-term corticosteroid treatment of upper respiratory tract infection . Pediatrics . 1988;;81:624-628.
Lemanske RF Jr, Henke KG.  Exercise-induced asthma . In: Gisolfi CV, Lamb DR, eds. Perspectives in Exercise Science and Sports Medicine: Youth, Exercise, and Sport . Indianapolis, Ind: Benchmark Press Inc; 1989;:465-512.
Jarjour NN, Calhoun WJ.  Exercise-induced asthma is not associated with mast cell activation or airway inflammation . J Allergy Clin Immunol . 1992;;89:60-65. Abstract.
Cypcar D, Lemanske RF Jr.  Asthma and exercise . Clin Chest Med . 1994;;15:351-368.
Kowabori I, Pierson WE, Loveday LC, Bierman CW.  Incidence of exercise-induced asthma in children . J Allergy Clin Immunol . 1976;;58:447-455.
McFadden ER, Gilbert IA.  Exercise-induced asthma . N Engl J Med . 1994;;330:1362-1367.
Anderson SD.  Exercise-induced asthma . In: Middleton E Jr, Reed CE, Ellis EF, Yunginger JW, Adkinson NF Jr, Busse WW, eds. Allergy: Principles and Practice . St Louis: Mosby-Year Book Inc; 1993;:1343-1365.
Bittleman DB, Smith RJH, Weiler JM.  Abnormal movement of the arytenoid region during exercise presenting as exercise-induced asthma in an adolescent athlete . Chest . 1994;;106:615-616.
Meltzer EO, Orgel HA, Kemp JP, et al.  Vocal cord dysfunction in a child with asthma . J Asthma . 1991;;28:141-145.
Chan-Yeung M.  Occupational asthma . Am Rev Respir Dis . 1986;;133:686-703.
Bush RK, Asbury D.  Aspirin-sensitive asthma . In: Busse WW, Holgate ST, eds. Asthma and Rhinitis . Boston, Mass: Blackwell Scientific Publications; 1995;:1429-1439.
Christie PE, Tagari P, Ford-Hutchinson AW, et al.  Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects . Am Rev Respir Dis . 1991;;143:1025-1029.
Israel E, Fischer AR, Rosenberg MA, et al.  The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin . Am Rev Respir Dis . 1993;;148:1447-1451.
Fischer AR, Rosenberg MA, Lilly CM, et al.  Direct evidence for role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma . J Allergy Clin Immunol . 1994;;94:1046-1056.
Sontag SJ, Schnell TG, Miller TQ, et al.  Prevalence of oesophagitis in asthmatics . Gut . 1992;;33:872-876.
Simpson WG.  Gastroesophageal reflux disease and asthma: diagnosis and management . Arch Intern Med . 1995;;155:798-803.
Busse WW, Kiecolt-Glaser JK, Coe C, Martin RJ, Weiss ST, Parker SR.  NHLBI Workshop summary: stress and asthma . Am J Respir Crit Care Med . 1995;;151:249-252.
Crapo R.  Pulmonary function testing . N Engl J Med . 1994;;331:25-30.
Sheffer AL.  Guidelines for the Diagnosis and Management of Asthma: National Heart, Lung, and Blood Institute National Asthma Education Program Expert Panel Report . J Allergy Clin Immunol . 1991;;88:425-534.
Chan-Yeung M, Chang JH, Manfreda J, Ferguson A, Becker A.  Changes in peak flow, symptom score, and the use of medicatons during acute exacerbations of asthma . Am J Respir Crit Care Med . 1996;;154:889-893.
Cockcroft DW, Hargreave FE.  Airway hyperresponsiveness: definition, measurement, and clinical relevance . In: Kaliner MA, Barnes PJ, Persson CG, eds. Asthma: Its Pathology and Treatment . New York, NY: Marcel Dekker; 1991;:51-72.
Chatham M, Bleecker ER, Smith PL, Rosenthal RR, Mason P, Norman PS.  A comparison of histamine, methacholine, and exercise airway reactivity in normal and asthmatic subjects . Am Rev Respir Dis . 1982;;126:235-240.
Hargreave FE, Ryan G, Thomson NC, et al.  Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance . J Allergy Clin Immunol . 1981;;68:347-355.
Corbridge TC, Hall JB.  The assessment and management of adults with status asthmaticus . Am J Respir Crit Care Med . 1995;;151:1296-1316.
Roth A.  Hospital admissions of young children for status asthmaticus in Honolulu, Hawaii, 1986 to 1989 . Ann Allergy . 1993;;71:533-536.
Carruthers DM, Harrison BD.  Arterial blood gas analysis or oxygen saturation in the assessment of acute asthma? Thorax . 1995;;50:186-188.
Mayefsky JH, el-Shinaway Y.  The usefulness of pulse oximetry in evaluating acutely ill asthmatics . Pediatr Emerg Care . 1992;;8:262-264.
Virant FS, Shapiro GG.  Evaluation of the child with chronic cough and/or wheezing . In: Tinkelman DG, Naspitz CK, eds. Childhood Asthma: Pathophysiology and Treatment . New York, NY: Marcel Dekker Inc; 1993;:303-327.
National Asthma Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md: US Dept of Health and Human Services; 1991.
Christopher KL, Wood RP, Eckert RC, Blager FB, Raney RA, Souhrada JF.  Vocal-cord dysfunction presenting as asthma . N Engl J Med . 1983;;308:1566-1570.
Goldman J, Muers M.  Vocal cord dysfunction and wheezing . Thorax . 1991;;46:401-404.
Seiner JC, Staudenmayer H, Koepke JW, Harvey R, Christopher K.  Vocal cord dysfunction: the importance of psychologic factors and provocation challenge testing . J Allergy Clin Immunol . 1987;;79:726-733.
Gern JE, Lemanske RF Jr.  β-Adrenergic agonist therapy . Immunol Allergy Clin North Am . 1993;;13:839-860.
Nelson HS.  Drug therapy: beta-adrenergic bronchodilators . N Engl J Med . 1995;;333:499-506.
Howarth PH, Durham SR, Lee TH, Kay AB, Church MK, Holgate ST.  Influence of albuterol, cromolyn sodium, and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma . Am Rev Respir Dis . 1985;;132:986-992.
Sly RM, Heimlich EM, Busser RJ, Strick L.  Exercise-induced bronchospasm: evaluation of isoproterenol, phenylephrine and the combination . Ann Allergy . 1967;;25:324-330.
Twentyman OP, Finnerty JP, Harris A, Palmer J, Holgate ST.  Protection against allergen-induced asthma by salmeterol . Lancet . 1990;;336:1338-1342.
Green CP, Price JF.  Prevention of exercise induced asthma by inhaled salmeterol xinafoate . Arch Dis Child . 1992;;67:1014-1017.
Cockroft DW, McParland CP, Swystun VA, Rutherford BC.  Regular inhaled salbutamol and air-way responsiveness to allergen . Lancet . 1993;;342:833-837.
Bhagat R, Kalra S, Swystun VA, Cockroft DW.  Rapid onset of tolerance to the bronchoprotective effect of salmeterol . Chest . 1995;;108:1235-1239.
Kalra S, Swystun VA, Bhagat R, Cockroft DW.  Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol . Chest . 1996;;109:953-956.
Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP.  Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol . Respir Med . 1994;;88:363-368.
Sears MR, Taylor DR, Print CG, et al.  Regular inhaled beta-agonist treatment in bronchial asthma . Lancet . 1990;;336:1391-1396.
Spitzer WO, Suissa S, Ernst P, et al.  The use of beta-agonists and the risk of death and near death from asthma . N Engl J Med . 1992;;326:501-506.
McFadden ER Jr.  Perspectives in beta-2-agonist therapy: vox clamantis in deserto vel lux in tenebris? J Allergy Clin Immunol . 1995;;95:641-651.
Drazen JM, Israel E, Boushey HA, et al.  Comparison of regularly scheduled with as-needed use of albuterol in mild asthma . N Engl J Med . 1996;;335:841-847.
Pearlman DS, Chervinsky P, LaForce C, et al.  A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma . N Engl J Med . 1992;;327:1420-1425.
Gardiner PV, Ward C, Booth H, Allison A, Hendrick DJ, Walters EH.  Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics . Am J Respir Crit Care Med . 1994;;150:1006-1011.
Weinberger M, Hendeles L.  Theophylline . In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice . St Louis, Mo: Mosby-Year Book Inc; 1993;;120:816-855.
Hendeles L, Weinberger M, Szefler S.  Safety and efficacy of theophylline in children with asthma . J Pediatr . 1992;:177-183.
Jusko WJ, Gardner MJ, Mangione A, Schentag JJ, Koup JR, Vance JW.  Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol . J Pharm Sci . 1979;;68:1358-1366.
Furukawa CT, Shapiro GG, Bierman CW, Kraemer MJ, Ward DJ, Pierson WE.  A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma . Pediatrics . 1984;;76:453-459.
Rachelefsky GS, Wo J, Adelson J, et al.  Behavior abnormalities and poor school performance due to oral theophylline use . Pediatrics . 1986;;78:1133-1138.
Lindgren S, Lokshin B, Stromquist A, et al.  Does asthma or treatment with theophylline limit children's academic performance? N Engl J Med . 1992;;327:926-930.
Bender BG, Lerner JA, Ikle D, Comer C, Szefler S.  Psychological change associated with theophylline treatment of asthmatic children: a 6-month study . Pediatr Pulmonol . 1991;;11:233-244.
Bender B, Milgrom H.  Theophylline-induced behavior change in children: an objective measure of parents' perceptions . JAMA . 1992;;267:2621-2624.
Gross NJ, Skorodin MS.  Anti-cholinergic, antimuscarinic bronchodilators . Am Rev Respir Dis . 1984;;129:856-870.
Schuh S, Johnson DW, Callahan S, Canny G, Levison H.  Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma . J Pediatr . 1995;;126:639-645.
Osmond MH, Klassen TP.  Efficacy of ipratropium bromide in acute childhood asthma: a metaanalysis . Acad Emerg Med . 1995;;2:651-656.
Karpel JP, Schacter EN, Fanta C, et al.  A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma . Chest . 1996;;110:611-616.
Rohr AS, Siegel SC, Katz RM, Rachelefsky GS, Spector SL, Lanier R.  A comparison of inhaled albuterol and cromolyn in the prophylaxis of exercise-induced bronchospasm . Ann Allergy . 1987;;59:107-109.
Petty TL, Rollins DR, Christopher K, Good JT, Oakley R.  Cromolyn sodium is effective in adult chronic asthmatics . Am Rev Respir Dis . 1989;;139:694-701.
Schwartz HJ, Blumenthal M, Brady R, et al.  A comparative study of the clinical efficacy of nedocromil sodium and placebo: how does cromolyn sodium compare as an active control treatment? Chest . 1996;;109:945-952.
Bel EH, Timmers MC, Hermans J, Dijkman JH, Sterk RJ.  The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects . Am Rev Respir Dis . 1990;;141:21-28.
Shapiro GG, Sharpe M, DeRouen TA, et al.  Cromolyn versus triamcinalone acetonide for youngsters with moderate asthma . J Allergy Clin Immunol . 1991;;88:742-748.
Alton EWFW, Kingsleigh-Smith DJ, Munkonge FM, et al.  Asthma prophylaxis agents alter the function of an airway epithelial chloride channel . Am J Respir Cell Mol Biol . 1996;;14:380-387.
Lal S, Dorow PD, Venho KK, Chatterjee SS.  Nedocromil sodium is more effective than cromolyn sodium for the treatment of chronic reversible obstructive airway disease . Chest . 1993;;104:438-447.
Settipane GA, Klein DE, Boyd GK, Sturam JH, Freye HB, Weltman JK.  Adverse reactions to cromolyn . JAMA . 1979;;241:811-813.
Armenio L, Baldini G, Bardare M, et al.  Double-blind, placebo controlled study of nedocromil sodium in asthma . Arch Dis Child . 1993;;68:193-197.
Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN.  Leukotrienes and lipoxins: structures, biosynthesis, and biologic effects . Science . 1987;;237:1171-1176.
Henderson WR.  The role of leukotrienes in inflammation . Ann Intern Med . 1994;;121:684-697.
Taylor I, O'Shaughnessy K, Fuller R, Dollery C.  Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects . Lancet . 1991;;337:690-694.
Finnerty JP, Wood-Baker R, Thomson H, Holgate ST.  Role of leukotrienes in exercise-induced asthma . Am Rev Respir Dis . 1992;;145:746-749.
Spector SL, Smith L, Glass M, Accolate Asthma Trialists Group.  Effects of 6 weeks of therapy with oral doses of ICI 204.219, aleukotriene D4 antagonist, in subjects with bronchial asthma . Am J Respir Crit Care Med . 1995;;150:618-623.
Meltzer SS, Hasday JD, Cohn J, Bleecker ER.  Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor . Am J Respir Crit Care Med . 1996;;153:931-935.
Israel E, Cohn J, Dube L, Drazen JM.  Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma: a randomized controlled trial . JAMA . 1996;;275:931-936.
Tamaoki J, Kondo M, Sakai N, et al.  Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid . Am J Respir Crit Care Med . 1997;;155:1235-1240.
Schleimer RP.  Glucocorticosteroids: their mechanisms of action and use in allergic diseases . In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice . St Louis, Mo: Mosby-Year Book Inc; 1993;:893-925.
Barnes PJ.  Mechanisms of action of glucocorticoids in asthma . Am J Respir Crit Care Med . 1996;;154:521-527.
Quinn JM.  The side effects of inhaled corticosteroids . Insights Allergy . 1994;;9:1-8.
Konig P.  The risks and benefits of inhaled corticosteroids . Eur J Respir Dis . 1993;;15:501-510.
Allen DB, Mullen M, Mullen B.  A meta-analysis of the effect of oral and inhaled corticosteroids on growth . J Allergy Clin Immunol . 1994;;93:967-976.
Cumming RG, Mitchell P, Leeder SR.  Use of inhaled corticosteroids and the risk of cataracts . N Engl J Med . 1997;;337:8-14.
Van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, et al.  Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma . Am Rev Respir Dis . 1992;;146:547-554.
Kamada AK, Szefler SJ, Martin RJ, et al.  Issues in the use of inhaled glucocorticoids . Am J Respir Crit Care Med . 1996;;153:1739-1748.
Wolthers OD, Pedersen S.  Short term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate . Arch Dis Child . 1995;;68:673-676.
Tinkelman DG, Reed CE, Nelson HS, Offord KP.  Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children . Pediatrics . 1993;;92:64-77.
Ferguson AC, Murray AB, Tze W.  Short stature and delayed skeletal maturation in children with allergic disease . J Allergy Clin Immunol . 1982;;69:461-466.
Balfour-Lynn L.  Growth and childhood asthma . Arch Dis Child . 1986;;61:1049-1055.
Abramson MJ, Puy RM, Weiner JM.  Is allergen immunotherapy effective in asthma? a metaanalysis of randomized controlled trials . Am J Respir Crit Care Med . 1995;;151:969-974.
Creticos PS, Reed CE, Norman PS, et al.  Rag-weed immunotherapy in adult asthma . N Engl J Med . 1996;;334:501-506.
Adkinson NF Jr, Eggleston PA, Eney D, et al.  A controlled trial of immunotherapy for asthma in allergic children . N Engl J Med . 1997;;336:324-331.
Newhouse MT, Dolovich MB.  Control of asthma by aerosols . N Engl J Med . 1986;;315:870-874.
Morrow PE.  Aerosol characterization and deposition . Am Rev Respir Dis . 1974;;110:88-99.
Newhouse MT.  Pulmonary drug targeting with aerosols: principles and clinical applications in adults and children . Am J Asthma Allergy Pediatr . 1993;;7:23-35.
Summer W, Elston R, Tharpe L, Nelson S, Haponick EF.  Aerosol bronchodilator delivery methods: relative impact on pulmonary function and cost of respiratory care . Arch Intern Med . 1989;;149:618-623.
Berenberg MJ, Baigelman W, Cupples LA, Pearce L.  Comparison of metered-dose inhaler attached to an Aerochamber with updraft nebulizer for the administration of metaproternol in hospitalized patients . J Asthma . 1985;;22:87-92.
Newhouse MT.  Emergency department management of life-threatening asthma: are nebulizers obsolete? Chest . 1993;;103:661-662.
Karem E, Levison H, Schuh S, et al.  Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma . J Pediatr . 1993;;123:313-317.
Toogood JH.  Helping your patients make better use of MDIs and spacers . J Respir Dis . 1994;;15:151-165.
Cunningham SJ, Crain EF.  Reduction of morbidity in asthmatic children given a spacer device . Chest . 1994;;106:753-757.
Salzman GA, Pyszczynski DR.  Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber . J Allergy Clin Immunol . 1988;;81:424-428.
Ortega-Carr D, Busse WW.  Specific problems: asthma in pregnancy and pre-menses . In: O'Byrne P, Thompson NC, eds. Manual of Asthma Management . London, England: WB Saunders Co; 1995;:653-671.
Schatz M, Zeiger RS, Hoffman CP, et al.  Perinatal outcomes in the pregnancies of asthmatic women: a prospective controlled analysis . Am J Respir Crit Care Med . 1995;;151:1170-1174.
Fitsimmons R, Greenberger PA, Patterson R.  Outcomes of pregnancy in women requiring corticosteroids for severe asthma . J Allergy Clin Immunol . 1986;;8:349-355.
Wald ER, Milmoe GJ, Bowen A, Ledesma-Medina J, Salamon N, Bluestone CD.  Acute maxillary sinusitis in children . N Engl J Med . 1981;;304:749-754.
Rachelefsky GS, Katz RM, Siegel SC.  Chronic sinus disease with associated reactive airway disease in children . Pediatrics . 1984;;73:526-529.
Friedman R, Ackerman M, Wald E, Casselbrant M, Friday G, Fireman P.  Asthma and bacterial sinusitis in children . J Allergy Clin Immunol . 1984;;74:185-189.
Goldenhersh MJ, Rachelefsky GS, Dudley J, et al.  The microbiology of chronic sinus disease in children with respiratory allergy . J Allergy Clin Immunol . 1990;;85:1030-1039.
Slavin RG.  Nasal polyps and sinusitis . In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice . St Louis, Mo: Mosby—Year Book Inc; 1993;:1455-1470.
Kingston HG, Hirshman CA.  Perioperative management of the patient with asthma . Anesth Analg . 1984;;63:844-855.
Oh SH, Patterson R.  Surgery in corticosteroiddependent asthmatics . J Allergy Clin Immunol . 1974;;53:345-351.
Neeld DA, Goodman LR, Gurney JW, Greenberger PA, Fink JN.  Computerized tomography in the evaluation of allergic bronchopulmonary aspergillosis . Am Rev Respir Dis . 1990;;142:1200-1205.
Greenberger PA.  Allergic bronchopulmonary aspergillosis . J Allergy Clin Immunol . 1984;;74:645-653.
Fraser CM, Nelson HS, Middleton E Jr.  Adrenergic agents . In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice . St Louis, Mo: Mosby—Year Book Inc; 1993;:778-815.
Tipton WR, Nelson HS.  Frequent parenteral terbutaline in the treatment of status asthmaticus in children . Ann Allergy . 1987;;58:252-256.
Schuh S, Parkin P, Rajan A, et al.  High- versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma . Pediatrics . 1989;;83:513-518.
Wolfe JD, Yamate M, Biedermann AA, Chu TJ.  Comparison of the acute cardiopulmonary effects of oral albuterol, metaproterenol, and terbutaline in asthmatics . JAMA . 1985;;253:2068-2072.
Fanta CH, Fossing TH, McFadden ER.  Treatment of acute asthma: is combination therapy with sympathomimetics and methylxanthines indicated? Am J Med . 1986;;80:5-10.
Appel D, Karpel JP, Sherman M.  Epinephrine improves expiratory flow rates in patients with asthma who do not respond to inhaled metaproterenol sulfate . J Allergy Clin Immunol . 1989;;84:90-98.
Mestitz H, Copland JM, McDonald CF.  Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic airflow obstruction . Chest . 1989;;96:1237-1240.
Berry RB, Shinto RA, Wong FH, Despars JA, Light RW.  Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD . Chest . 1989;;96:1241-1246.
Robertson CF, Smith F, Beck R, Levison H.  Response to frequent low doses of nebulized salbutamol in acute asthma . J Pediatr . 1985;;106:672-674.
Wrenn K, Slovis CM, Murphy F, Greenberg RS.  Aminophylline therapy for acute bronchospastic disease in the emergency room . Ann Intern Med . 1991;;115:241-247.
Huang D, O'Brien RG, Harman E, et al.  Does aminophylline benefit adults admitted to the hospital for an acute exacerbation of asthma? Ann Intern Med . 1993;;119:1155-1160.
Littenberg B.  Aminophylline treatment in severe, acute asthma: a meta-analysis . JAMA . 1988;;259:1678-1684.
Carter E, Cruz M, Chesrown S, Shieh G, Reilly K, Hendeles L.  Efficacy of intravenously administered theophylline in children hospitalized with severe asthma . J Pediatr . 1993;;122:470-476.
Strauss RE, Wertheim DL, Bonagura VR, Valacer DJ.  Aminophylline therapy does not improve outcome and increases adverse effects in children hospitalized with acute asthmatic exacerbations . Pediatrics . 1994;;93:205-210.
McFadden ER Jr.  Dosages of corticosteroids in asthma . Am Rev Respir Dis . 1993;;147:1306-1310.
Chapman KR, Verbeek PR, White JG, Rebuck RS.  Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma . N Engl J Med . 1991;;324:788-794.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Sandford A, Weir T, Pare P.  The genetics of asthma . Am J Respir Crit Care Med . 1996;;153:1749-1765.
Cookson WOCM, Sharp PA, Faux JA, Hopkin JM.  Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q . Lancet . 1989;;1:1292-1295.
Moffatt MF, Sharp PA, Faux JA, Young RP, Cookson WOCM, Hopkin JM.  Factors confounding genetic linkage between atopy and chromosone 1 lq . Clin Exp Allergy . 1992;;22:1046-1051.
Marsh DG, Neely JD, Breazeale DR, et al.  Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations . Science . 1994;;264:1152-1156.
Postma DS, Bleecker ER, Amelung PJ, et al.  Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy . N Engl J Med . 1995;;333:894-900.
Moffatt MF, Hill MR, Cornelis F, et al.  Genetic linkage of T-cell receptor alpha/delta complex to specific IgE responses . Lancet . 1994;;343:1597-1600.
Lemanske RF Jr, Kaliner MA.  The assessment of autonomic nervous system function . In: Spector SL, ed. Provocative Challenge Procedures: Background and Methodology . Mount Kisco, NY: Futura Publishing Co Inc; 1989;:131-166.
Reihsaus EM, Innis M, MacIntyre N, Liggett SB.  Mutations in the gene encoding for the β2-adrenergic receptor in normal and asthmatic subjects . Am J Respir Cell Mol Biol . 1993;;8:334-339.
Green SA, Turki J, Innis M, Liggett SB.  Aminoterminal polymorphisms of the human β2-adrenergic receptor impart distinct agonist-promoted regulatory properties . Biochemistry . 1994;;33:9414-9419.
Turki J, Pak J, Green A, Martin RJ, Liggett SB.  Genetic polymorphisms of the β2-adrenergic receptor in nocturnal and nonnocturnal asthma . J Clin Invest . 1995;;95:1635-1641.
Hall IP, Wheatley A, Wilding P, Liggett SB.  Association of Glu 27 β2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects . Lancet . 1995;;345:1213-1214.
Bai TR, Mak JCW, Barnes PJ.  A comparison of beta-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle . Am J Respir Cell Mol Biol . 1992;;6:647-651.
Bai TR.  Abnormalities in airway smooth muscle in fatal asthma . Am Rev Respir Dis . 1990;;141:552-557.
Metzger WJ, Zavala D, Richerson HB, et al.  Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs: description of the model and local airway inflammation . Am Rev Respir Dis . 1987;;135:433-440.
Frick RB, Metzger WJ, Richerson HB, et al.  Increased bronchovascular permeability afterallergen exposure in sensitive asthmatics . J Appl Physiol . 1987;;63:1147-1155.
Wiggs BR, Bosken C, Pare PD, James A, Hogg JC.  A model of airway narrowing in asthma and in chronic obstructive pulmonary disease . Am Rev Respir Dis . 1992;;145:1251-1258.
Lundgren JD, Shelhamer JH.  Pathogenesis of airway mucus hypersecretion . J Allergy Clin Immunol . 1990;;85:399-417.
McFadden ER Jr, Gilbert IA.  Asthma . N Engl J Med . 1992;;327:1928-1937.
Salvato G.  Some histologic changes in chronic bronchitis and asthma . Thorax . 1968;;23:168-172.
Cutz E, Levison H, Cooper DM.  Ultrastructure of airways in children with asthma . Histopathology . 1978;;2:407-421.
Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI.  Cytokines in symptomatic asthma airways . J Allergy Clin Immunol . 1992;;89:958-967.
Vittori E, Marini M, Fasoli A, de Franchis R, Mattoli S.  Increased expression of endothelin in bronchial epithelial cells of asthmatic patients and effect of corticosteroids . Am Rev Respir Dis . 1992;;146:1320-1325.
Leff AR, Hamann KJ, Wegner CD.  Inflammation and cell-cell interactions in airway hyperresponsiveness . Am J Physiol . 1991;;260:L189-L206.
Colasurdo GN, Larsen GL.  Airway hyperresponsiveness . In: Busse WW, Holgate ST, eds. Asthma and Rhinitis . Boston, Mass: Blackwell Scientific Publications;1995;:1044-1056.
Hargreave FE, Dolovich J, O'Byrne PM, Ramsdale EH, Daniel EE.  The origin of airway hyperresponsiveness . J Allergy Clin Immunol . 1986;;78:825-832.
Smith L, McFadden ER Jr.  Bronchial hyperreactivity revisited . Ann Allergy Asthma Immunol . 1995;;74:454-469.
Hoag JE, McFadden ER Jr.  Long-term effect of cromolyn sodium on nonspecific bronchial hyperresponsiveness: a review . Ann Allergy . 1991;;66:53-63.
Lenfant C, Khaltaev N.  Global Initiative for Asthma . In: Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report . 1993;;1:1-176.
Evans R, Mullally DI, Wilson RW, et al.  National trends in the morbidity and mortality of asthma in the US . Chest . 1987;;91( (suppl) ):65S-74S.
Halfon N, Newacheck PW.  Childhood asthma and poverty: differential impacts and utilization of health services . Pediatrics . 1993;;91:56-61.
Call RS, Smith TF, Morris E, Chapman MD, Platts-Mills TAE.  Risk factors for asthma in inner city children . J Pediatr . 1992;;121:862-866.
Banner AS.  The increase in asthma prevalence . Chest . 1995;;108:301-302.
Jenkins MA, Hopper JL, Bowes G, Carlin JB, Flander LB, Giles GG.  Factors in childhood as predictors of asthma in adult life . BMJ . 1994;;309:90-93.
Oliveti JF, Kercsmar CM, Redline S.  Pre- and perinatal risk factors for asthma in inner city African-American children . Am J Epidemiol . 1996;;143:570-577.
Lemanske RF Jr, Kaliner MA.  Late phase allergic reactions . In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice . St Louis, Mo: Mosby-Year Book Inc; 1993;:320-361.
Niemeijer NR, de Monchy JGR.  Age-dependency of sensitization to aero-allergens in asthmatics . Allergy . 1992;;47:431-435.
Duff AL, Platts-Mills TAE.  Allergens and asthma . Pediatr Clin North Am . 1992;;39:1277-1291.
Platts-Mills TAE, Tovey ER, Mitchell EB, Moszoro H, Nock P, Wilkins SR.  Reduction of bronchial reactivity during prolonged allergen avoidance . Lancet . 1982;;1:675-678.
Reid MJ, Moss RB, Hsu YP, Kwasnicki JM, Commerford TM, Nelson BL.  Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy . J Allergy Clin Immunol . 1986;;78:590-600.
O'Hollaren MT, Yunginger JW, Offard KP, et al.  Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma . N Engl J Med . 1991;;324:359-363.
James JM, Bernhisel-Broadbent J, Sampson HA.  Respiratory reactions provoked by double-blind food challenges in children . Am J Respir Crit Care Med . 1994;;149:59-64.
Morgan WJ, Martinez FD.  Risk factors for developing wheezing and asthma in childhood . In: Stempel DA, Szelfer SJ, eds. Pediatric Clinics of North America . Philadelphia, Pa: WB Saunders Co; 1992;:1185-1203.
Halonen M, Stern D, Taussig LM, Wright A, Ray CG, Martinez FD.  The predictive relationship between serum IgE levels at birth and subsequent incidences oflower respiratory illnesses and eczema in infants . Am Rev Respir Dis . 1992;;146:866-870.
Martinez FD, Wright AL, Taussig LM, et al.  Asthma and wheezing in the first six years of life . N Engl J Med . 1995;;332:133-138.
Bleecker ER, Amelung PJ, Levitt RC, Postma DS, Meyers DA.  Evidence for linkage of total serum IgE and bronchial hyperresponsiveness to chromosome 5q: a major regulatory locus important in asthma . Clin Exp Allergy . 1995;;25:84-88.
Sunyer J, Anto JM, Castellsague J, Soriano JB, Roca J, Spanish Group of the European Study of Asthma.  Total serum IgE is associated with asthma independently of specific IgE levels . Eur Respir J . 1996;;9:1880-1884.
Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG.  Association of asthma with serum IgE levels and skin-test reactivity to allergens . N Engl J Med . 1989;;320:271-277.
Robinson DS, Hamid Q, Ying S, et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma . N Engl J Med . 1992;;326:298-304.
Anderson GP, Coyle AJ.  TH2 and 'TH2-like' cells in allergy and asthma: pharmacologic perspectives . Trends Pharmacol Sci . 1994;;15:324-332.
Cockcroft DW, Murdock KY.  Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, and increased bronchial responsiveness to histamine . J Allergy Clin Immunol . 1987;;79:734-740.
Brogden RN, Sorkin EM.  Nedocromil sodium: an updated review of its pharmacologic properties and therapeutic efficacy in asthma . Drugs . 1993;;45:693-715.
de Jong JW, Teengs JP, Postma DS, et al.  Nedocromil sodium versus albuterol in the management of allergic asthma . Am J Respir Crit Care Med . 1994;;149:91-97.
Pizzichini MMM, Kidney JC, Wong BJO, et al.  Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses . Eur Respir J . 1996;;9:449-455.
Twentyman OP, Finnerty JP, Holgate ST.  The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma . Am Rev Respir Dis . 1991;;144:782-787.
Lai CKW, Twentyman OP, Holgate ST.  The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in non-specific bronchial responsiveness . Am Rev Respir Dis . 1989;;140:917-923.
Page C, Costello J.  Why beta-agonists should not be used regularly . Respir Med . 1992;;86:477-479.
Martinez FD, Morgan WJ, Wright AL, Holberg C, Taussig LM.  Initial airway function is a risk factor for recurrent wheezing respiratory illnesses during the first three years of life . Am Rev Respir Dis . 1991;;143:312-316.
Martinez F, Cline M, Burrows B.  Increased incidence of asthma in children of smoking mothers . Pediatrics . 1992;;89:21-26.
Duff AL, Pomeranz ES, Gelber LE, et al.  Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens . Pediatrics . 1993;;92:535-540.
Cypcar D, Stark J, Lemanske RF Jr.  The impact of respiratory infections on asthma . Pediatr Clin North Am . 1992;;39:1259-1276.
Johnston SL, Pattemore PK, Sanderson G, et al.  Community study of role of viral infections in exacerbations of asthma in 9-11 year old children . BMJ . 1995;;310:1225-1228.
Nicholson KG, Kent J, Hammersley V, Cancio E.  Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study . BMJ . 1996;;313:1119-1123.
Lemanske RF Jr, Dick EC, Swenson CA, Vrtis RF, Busse WW.  Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions . J Clin Invest . 1989;;83:1-10.
Calhoun WJ, Dick EC, Schwartz LB, Busse WW.  A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects . J Clin Invest . 1994;;94:2200-2208.
Einarsson O, Geba GP, Zhu Z, Landry M, Elias JA.  Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness . J Clin Invest . 1996;;4:915-924.
Connett G, Lenney W.  Prevention of viral induced asthma attacks using inhaled budesonide . Arch Dis Child . 1993;;68:85-87.
Brunette MG, Lands L, Thibodeau L.  Childhood asthma: prevention of attacks with short-term corticosteroid treatment of upper respiratory tract infection . Pediatrics . 1988;;81:624-628.
Lemanske RF Jr, Henke KG.  Exercise-induced asthma . In: Gisolfi CV, Lamb DR, eds. Perspectives in Exercise Science and Sports Medicine: Youth, Exercise, and Sport . Indianapolis, Ind: Benchmark Press Inc; 1989;:465-512.
Jarjour NN, Calhoun WJ.  Exercise-induced asthma is not associated with mast cell activation or airway inflammation . J Allergy Clin Immunol . 1992;;89:60-65. Abstract.
Cypcar D, Lemanske RF Jr.  Asthma and exercise . Clin Chest Med . 1994;;15:351-368.
Kowabori I, Pierson WE, Loveday LC, Bierman CW.  Incidence of exercise-induced asthma in children . J Allergy Clin Immunol . 1976;;58:447-455.
McFadden ER, Gilbert IA.  Exercise-induced asthma . N Engl J Med . 1994;;330:1362-1367.
Anderson SD.  Exercise-induced asthma . In: Middleton E Jr, Reed CE, Ellis EF, Yunginger JW, Adkinson NF Jr, Busse WW, eds. Allergy: Principles and Practice . St Louis: Mosby-Year Book Inc; 1993;:1343-1365.
Bittleman DB, Smith RJH, Weiler JM.  Abnormal movement of the arytenoid region during exercise presenting as exercise-induced asthma in an adolescent athlete . Chest . 1994;;106:615-616.
Meltzer EO, Orgel HA, Kemp JP, et al.  Vocal cord dysfunction in a child with asthma . J Asthma . 1991;;28:141-145.
Chan-Yeung M.  Occupational asthma . Am Rev Respir Dis . 1986;;133:686-703.
Bush RK, Asbury D.  Aspirin-sensitive asthma . In: Busse WW, Holgate ST, eds. Asthma and Rhinitis . Boston, Mass: Blackwell Scientific Publications; 1995;:1429-1439.
Christie PE, Tagari P, Ford-Hutchinson AW, et al.  Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects . Am Rev Respir Dis . 1991;;143:1025-1029.
Israel E, Fischer AR, Rosenberg MA, et al.  The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin . Am Rev Respir Dis . 1993;;148:1447-1451.
Fischer AR, Rosenberg MA, Lilly CM, et al.  Direct evidence for role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma . J Allergy Clin Immunol . 1994;;94:1046-1056.
Sontag SJ, Schnell TG, Miller TQ, et al.  Prevalence of oesophagitis in asthmatics . Gut . 1992;;33:872-876.
Simpson WG.  Gastroesophageal reflux disease and asthma: diagnosis and management . Arch Intern Med . 1995;;155:798-803.
Busse WW, Kiecolt-Glaser JK, Coe C, Martin RJ, Weiss ST, Parker SR.  NHLBI Workshop summary: stress and asthma . Am J Respir Crit Care Med . 1995;;151:249-252.
Crapo R.  Pulmonary function testing . N Engl J Med . 1994;;331:25-30.
Sheffer AL.  Guidelines for the Diagnosis and Management of Asthma: National Heart, Lung, and Blood Institute National Asthma Education Program Expert Panel Report . J Allergy Clin Immunol . 1991;;88:425-534.
Chan-Yeung M, Chang JH, Manfreda J, Ferguson A, Becker A.  Changes in peak flow, symptom score, and the use of medicatons during acute exacerbations of asthma . Am J Respir Crit Care Med . 1996;;154:889-893.
Cockcroft DW, Hargreave FE.  Airway hyperresponsiveness: definition, measurement, and clinical relevance . In: Kaliner MA, Barnes PJ, Persson CG, eds. Asthma: Its Pathology and Treatment . New York, NY: Marcel Dekker; 1991;:51-72.
Chatham M, Bleecker ER, Smith PL, Rosenthal RR, Mason P, Norman PS.  A comparison of histamine, methacholine, and exercise airway reactivity in normal and asthmatic subjects . Am Rev Respir Dis . 1982;;126:235-240.
Hargreave FE, Ryan G, Thomson NC, et al.  Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance . J Allergy Clin Immunol . 1981;;68:347-355.
Corbridge TC, Hall JB.  The assessment and management of adults with status asthmaticus . Am J Respir Crit Care Med . 1995;;151:1296-1316.
Roth A.  Hospital admissions of young children for status asthmaticus in Honolulu, Hawaii, 1986 to 1989 . Ann Allergy . 1993;;71:533-536.
Carruthers DM, Harrison BD.  Arterial blood gas analysis or oxygen saturation in the assessment of acute asthma? Thorax . 1995;;50:186-188.
Mayefsky JH, el-Shinaway Y.  The usefulness of pulse oximetry in evaluating acutely ill asthmatics . Pediatr Emerg Care . 1992;;8:262-264.
Virant FS, Shapiro GG.  Evaluation of the child with chronic cough and/or wheezing . In: Tinkelman DG, Naspitz CK, eds. Childhood Asthma: Pathophysiology and Treatment . New York, NY: Marcel Dekker Inc; 1993;:303-327.
National Asthma Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md: US Dept of Health and Human Services; 1991.
Christopher KL, Wood RP, Eckert RC, Blager FB, Raney RA, Souhrada JF.  Vocal-cord dysfunction presenting as asthma . N Engl J Med . 1983;;308:1566-1570.
Goldman J, Muers M.  Vocal cord dysfunction and wheezing . Thorax . 1991;;46:401-404.
Seiner JC, Staudenmayer H, Koepke JW, Harvey R, Christopher K.  Vocal cord dysfunction: the importance of psychologic factors and provocation challenge testing . J Allergy Clin Immunol . 1987;;79:726-733.
Gern JE, Lemanske RF Jr.  β-Adrenergic agonist therapy . Immunol Allergy Clin North Am . 1993;;13:839-860.
Nelson HS.  Drug therapy: beta-adrenergic bronchodilators . N Engl J Med . 1995;;333:499-506.
Howarth PH, Durham SR, Lee TH, Kay AB, Church MK, Holgate ST.  Influence of albuterol, cromolyn sodium, and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma . Am Rev Respir Dis . 1985;;132:986-992.
Sly RM, Heimlich EM, Busser RJ, Strick L.  Exercise-induced bronchospasm: evaluation of isoproterenol, phenylephrine and the combination . Ann Allergy . 1967;;25:324-330.
Twentyman OP, Finnerty JP, Harris A, Palmer J, Holgate ST.  Protection against allergen-induced asthma by salmeterol . Lancet . 1990;;336:1338-1342.
Green CP, Price JF.  Prevention of exercise induced asthma by inhaled salmeterol xinafoate . Arch Dis Child . 1992;;67:1014-1017.
Cockroft DW, McParland CP, Swystun VA, Rutherford BC.  Regular inhaled salbutamol and air-way responsiveness to allergen . Lancet . 1993;;342:833-837.
Bhagat R, Kalra S, Swystun VA, Cockroft DW.  Rapid onset of tolerance to the bronchoprotective effect of salmeterol . Chest . 1995;;108:1235-1239.
Kalra S, Swystun VA, Bhagat R, Cockroft DW.  Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol . Chest . 1996;;109:953-956.
Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP.  Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol . Respir Med . 1994;;88:363-368.
Sears MR, Taylor DR, Print CG, et al.  Regular inhaled beta-agonist treatment in bronchial asthma . Lancet . 1990;;336:1391-1396.
Spitzer WO, Suissa S, Ernst P, et al.  The use of beta-agonists and the risk of death and near death from asthma . N Engl J Med . 1992;;326:501-506.
McFadden ER Jr.  Perspectives in beta-2-agonist therapy: vox clamantis in deserto vel lux in tenebris? J Allergy Clin Immunol . 1995;;95:641-651.
Drazen JM, Israel E, Boushey HA, et al.  Comparison of regularly scheduled with as-needed use of albuterol in mild asthma . N Engl J Med . 1996;;335:841-847.
Pearlman DS, Chervinsky P, LaForce C, et al.  A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma . N Engl J Med . 1992;;327:1420-1425.
Gardiner PV, Ward C, Booth H, Allison A, Hendrick DJ, Walters EH.  Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics . Am J Respir Crit Care Med . 1994;;150:1006-1011.
Weinberger M, Hendeles L.  Theophylline . In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice . St Louis, Mo: Mosby-Year Book Inc; 1993;;120:816-855.
Hendeles L, Weinberger M, Szefler S.  Safety and efficacy of theophylline in children with asthma . J Pediatr . 1992;:177-183.
Jusko WJ, Gardner MJ, Mangione A, Schentag JJ, Koup JR, Vance JW.  Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol . J Pharm Sci . 1979;;68:1358-1366.
Furukawa CT, Shapiro GG, Bierman CW, Kraemer MJ, Ward DJ, Pierson WE.  A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma . Pediatrics . 1984;;76:453-459.
Rachelefsky GS, Wo J, Adelson J, et al.  Behavior abnormalities and poor school performance due to oral theophylline use . Pediatrics . 1986;;78:1133-1138.
Lindgren S, Lokshin B, Stromquist A, et al.  Does asthma or treatment with theophylline limit children's academic performance? N Engl J Med . 1992;;327:926-930.
Bender BG, Lerner JA, Ikle D, Comer C, Szefler S.  Psychological change associated with theophylline treatment of asthmatic children: a 6-month study . Pediatr Pulmonol . 1991;;11:233-244.
Bender B, Milgrom H.  Theophylline-induced behavior change in children: an objective measure of parents' perceptions . JAMA . 1992;;267:2621-2624.
Gross NJ, Skorodin MS.  Anti-cholinergic, antimuscarinic bronchodilators . Am Rev Respir Dis . 1984;;129:856-870.
Schuh S, Johnson DW, Callahan S, Canny G, Levison H.  Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma . J Pediatr . 1995;;126:639-645.
Osmond MH, Klassen TP.  Efficacy of ipratropium bromide in acute childhood asthma: a metaanalysis . Acad Emerg Med . 1995;;2:651-656.
Karpel JP, Schacter EN, Fanta C, et al.  A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma . Chest . 1996;;110:611-616.
Rohr AS, Siegel SC, Katz RM, Rachelefsky GS, Spector SL, Lanier R.  A comparison of inhaled albuterol and cromolyn in the prophylaxis of exercise-induced bronchospasm . Ann Allergy . 1987;;59:107-109.
Petty TL, Rollins DR, Christopher K, Good JT, Oakley R.  Cromolyn sodium is effective in adult chronic asthmatics . Am Rev Respir Dis . 1989;;139:694-701.
Schwartz HJ, Blumenthal M, Brady R, et al.  A comparative study of the clinical efficacy of nedocromil sodium and placebo: how does cromolyn sodium compare as an active control treatment? Chest . 1996;;109:945-952.
Bel EH, Timmers MC, Hermans J, Dijkman JH, Sterk RJ.  The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects . Am Rev Respir Dis . 1990;;141:21-28.
Shapiro GG, Sharpe M, DeRouen TA, et al.  Cromolyn versus triamcinalone acetonide for youngsters with moderate asthma . J Allergy Clin Immunol . 1991;;88:742-748.
Alton EWFW, Kingsleigh-Smith DJ, Munkonge FM, et al.  Asthma prophylaxis agents alter the function of an airway epithelial chloride channel . Am J Respir Cell Mol Biol . 1996;;14:380-387.
Lal S, Dorow PD, Venho KK, Chatterjee SS.  Nedocromil sodium is more effective than cromolyn sodium for the treatment of chronic reversible obstructive airway disease . Chest . 1993;;104:438-447.
Settipane GA, Klein DE, Boyd GK, Sturam JH, Freye HB, Weltman JK.  Adverse reactions to cromolyn . JAMA . 1979;;241:811-813.
Armenio L, Baldini G, Bardare M, et al.  Double-blind, placebo controlled study of nedocromil sodium in asthma . Arch Dis Child . 1993;;68:193-197.
Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN.  Leukotrienes and lipoxins: structures, biosynthesis, and biologic effects . Science . 1987;;237:1171-1176.
Henderson WR.  The role of leukotrienes in inflammation . Ann Intern Med . 1994;;121:684-697.
Taylor I, O'Shaughnessy K, Fuller R, Dollery C.  Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects . Lancet . 1991;;337:690-694.
Finnerty JP, Wood-Baker R, Thomson H, Holgate ST.  Role of leukotrienes in exercise-induced asthma . Am Rev Respir Dis . 1992;;145:746-749.
Spector SL, Smith L, Glass M, Accolate Asthma Trialists Group.  Effects of 6 weeks of therapy with oral doses of ICI 204.219, aleukotriene D4 antagonist, in subjects with bronchial asthma . Am J Respir Crit Care Med . 1995;;150:618-623.
Meltzer SS, Hasday JD, Cohn J, Bleecker ER.  Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor . Am J Respir Crit Care Med . 1996;;153:931-935.
Israel E, Cohn J, Dube L, Drazen JM.  Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma: a randomized controlled trial . JAMA . 1996;;275:931-936.
Tamaoki J, Kondo M, Sakai N, et al.  Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid . Am J Respir Crit Care Med . 1997;;155:1235-1240.
Schleimer RP.  Glucocorticosteroids: their mechanisms of action and use in allergic diseases . In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice . St Louis, Mo: Mosby-Year Book Inc; 1993;:893-925.
Barnes PJ.  Mechanisms of action of glucocorticoids in asthma . Am J Respir Crit Care Med . 1996;;154:521-527.
Quinn JM.  The side effects of inhaled corticosteroids . Insights Allergy . 1994;;9:1-8.
Konig P.  The risks and benefits of inhaled corticosteroids . Eur J Respir Dis . 1993;;15:501-510.
Allen DB, Mullen M, Mullen B.  A meta-analysis of the effect of oral and inhaled corticosteroids on growth . J Allergy Clin Immunol . 1994;;93:967-976.
Cumming RG, Mitchell P, Leeder SR.  Use of inhaled corticosteroids and the risk of cataracts . N Engl J Med . 1997;;337:8-14.
Van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, et al.  Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma . Am Rev Respir Dis . 1992;;146:547-554.
Kamada AK, Szefler SJ, Martin RJ, et al.  Issues in the use of inhaled glucocorticoids . Am J Respir Crit Care Med . 1996;;153:1739-1748.
Wolthers OD, Pedersen S.  Short term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate . Arch Dis Child . 1995;;68:673-676.
Tinkelman DG, Reed CE, Nelson HS, Offord KP.  Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children . Pediatrics . 1993;;92:64-77.
Ferguson AC, Murray AB, Tze W.  Short stature and delayed skeletal maturation in children with allergic disease . J Allergy Clin Immunol . 1982;;69:461-466.
Balfour-Lynn L.  Growth and childhood asthma . Arch Dis Child . 1986;;61:1049-1055.
Abramson MJ, Puy RM, Weiner JM.  Is allergen immunotherapy effective in asthma? a metaanalysis of randomized controlled trials . Am J Respir Crit Care Med . 1995;;151:969-974.
Creticos PS, Reed CE, Norman PS, et al.  Rag-weed immunotherapy in adult asthma . N Engl J Med . 1996;;334:501-506.
Adkinson NF Jr, Eggleston PA, Eney D, et al.  A controlled trial of immunotherapy for asthma in allergic children . N Engl J Med . 1997;;336:324-331.
Newhouse MT, Dolovich MB.  Control of asthma by aerosols . N Engl J Med . 1986;;315:870-874.
Morrow PE.  Aerosol characterization and deposition . Am Rev Respir Dis . 1974;;110:88-99.
Newhouse MT.  Pulmonary drug targeting with aerosols: principles and clinical applications in adults and children . Am J Asthma Allergy Pediatr . 1993;;7:23-35.
Summer W, Elston R, Tharpe L, Nelson S, Haponick EF.  Aerosol bronchodilator delivery methods: relative impact on pulmonary function and cost of respiratory care . Arch Intern Med . 1989;;149:618-623.
Berenberg MJ, Baigelman W, Cupples LA, Pearce L.  Comparison of metered-dose inhaler attached to an Aerochamber with updraft nebulizer for the administration of metaproternol in hospitalized patients . J Asthma . 1985;;22:87-92.
Newhouse MT.  Emergency department management of life-threatening asthma: are nebulizers obsolete? Chest . 1993;;103:661-662.
Karem E, Levison H, Schuh S, et al.  Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma . J Pediatr . 1993;;123:313-317.
Toogood JH.  Helping your patients make better use of MDIs and spacers . J Respir Dis . 1994;;15:151-165.
Cunningham SJ, Crain EF.  Reduction of morbidity in asthmatic children given a spacer device . Chest . 1994;;106:753-757.
Salzman GA, Pyszczynski DR.  Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber . J Allergy Clin Immunol . 1988;;81:424-428.
Ortega-Carr D, Busse WW.  Specific problems: asthma in pregnancy and pre-menses . In: O'Byrne P, Thompson NC, eds. Manual of Asthma Management . London, England: WB Saunders Co; 1995;:653-671.
Schatz M, Zeiger RS, Hoffman CP, et al.  Perinatal outcomes in the pregnancies of asthmatic women: a prospective controlled analysis . Am J Respir Crit Care Med . 1995;;151:1170-1174.
Fitsimmons R, Greenberger PA, Patterson R.  Outcomes of pregnancy in women requiring corticosteroids for severe asthma . J Allergy Clin Immunol . 1986;;8:349-355.
Wald ER, Milmoe GJ, Bowen A, Ledesma-Medina J, Salamon N, Bluestone CD.  Acute maxillary sinusitis in children . N Engl J Med . 1981;;304:749-754.
Rachelefsky GS, Katz RM, Siegel SC.  Chronic sinus disease with associated reactive airway disease in children . Pediatrics . 1984;;73:526-529.
Friedman R, Ackerman M, Wald E, Casselbrant M, Friday G, Fireman P.  Asthma and bacterial sinusitis in children . J Allergy Clin Immunol . 1984;;74:185-189.
Goldenhersh MJ, Rachelefsky GS, Dudley J, et al.  The microbiology of chronic sinus disease in children with respiratory allergy . J Allergy Clin Immunol . 1990;;85:1030-1039.
Slavin RG.  Nasal polyps and sinusitis . In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice . St Louis, Mo: Mosby—Year Book Inc; 1993;:1455-1470.
Kingston HG, Hirshman CA.  Perioperative management of the patient with asthma . Anesth Analg . 1984;;63:844-855.
Oh SH, Patterson R.  Surgery in corticosteroiddependent asthmatics . J Allergy Clin Immunol . 1974;;53:345-351.
Neeld DA, Goodman LR, Gurney JW, Greenberger PA, Fink JN.  Computerized tomography in the evaluation of allergic bronchopulmonary aspergillosis . Am Rev Respir Dis . 1990;;142:1200-1205.
Greenberger PA.  Allergic bronchopulmonary aspergillosis . J Allergy Clin Immunol . 1984;;74:645-653.
Fraser CM, Nelson HS, Middleton E Jr.  Adrenergic agents . In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice . St Louis, Mo: Mosby—Year Book Inc; 1993;:778-815.
Tipton WR, Nelson HS.  Frequent parenteral terbutaline in the treatment of status asthmaticus in children . Ann Allergy . 1987;;58:252-256.
Schuh S, Parkin P, Rajan A, et al.  High- versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma . Pediatrics . 1989;;83:513-518.
Wolfe JD, Yamate M, Biedermann AA, Chu TJ.  Comparison of the acute cardiopulmonary effects of oral albuterol, metaproterenol, and terbutaline in asthmatics . JAMA . 1985;;253:2068-2072.
Fanta CH, Fossing TH, McFadden ER.  Treatment of acute asthma: is combination therapy with sympathomimetics and methylxanthines indicated? Am J Med . 1986;;80:5-10.
Appel D, Karpel JP, Sherman M.  Epinephrine improves expiratory flow rates in patients with asthma who do not respond to inhaled metaproterenol sulfate . J Allergy Clin Immunol . 1989;;84:90-98.
Mestitz H, Copland JM, McDonald CF.  Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic airflow obstruction . Chest . 1989;;96:1237-1240.
Berry RB, Shinto RA, Wong FH, Despars JA, Light RW.  Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD . Chest . 1989;;96:1241-1246.
Robertson CF, Smith F, Beck R, Levison H.  Response to frequent low doses of nebulized salbutamol in acute asthma . J Pediatr . 1985;;106:672-674.
Wrenn K, Slovis CM, Murphy F, Greenberg RS.  Aminophylline therapy for acute bronchospastic disease in the emergency room . Ann Intern Med . 1991;;115:241-247.
Huang D, O'Brien RG, Harman E, et al.  Does aminophylline benefit adults admitted to the hospital for an acute exacerbation of asthma? Ann Intern Med . 1993;;119:1155-1160.
Littenberg B.  Aminophylline treatment in severe, acute asthma: a meta-analysis . JAMA . 1988;;259:1678-1684.
Carter E, Cruz M, Chesrown S, Shieh G, Reilly K, Hendeles L.  Efficacy of intravenously administered theophylline in children hospitalized with severe asthma . J Pediatr . 1993;;122:470-476.
Strauss RE, Wertheim DL, Bonagura VR, Valacer DJ.  Aminophylline therapy does not improve outcome and increases adverse effects in children hospitalized with acute asthmatic exacerbations . Pediatrics . 1994;;93:205-210.
McFadden ER Jr.  Dosages of corticosteroids in asthma . Am Rev Respir Dis . 1993;;147:1306-1310.
Chapman KR, Verbeek PR, White JG, Rebuck RS.  Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma . N Engl J Med . 1991;;324:788-794.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.